# Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency

> **NCT01756365** · NA · RECRUITING · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 54 (estimated)

## Conditions studied

- Limbal Stem Cell Deficiency

## Interventions

- **PROCEDURE:** Surgical transplantation of ACCE

## Key facts

- **NCT ID:** NCT01756365
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2012-12
- **Primary completion:** 2025-12
- **Final completion:** 2027-12
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756365, "Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01756365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*